Regen Biopharma Inc 's

• RGBP's Stock Performance relative to its Competitors

Xbiotech Inc Share Performance -7.56% This Year

Xbiotech Inc Profile Xbiotech Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic antibodies. They seek to address unmet medical needs by leveraging their proprietary True Human antibody technology. More about Xbiotech Inc 's Market Share

Opko Health Inc Share Performance +15.00% This Quarter

Opko Health Inc Profile Opko Health Inc is a biotechnology and pharmaceutical company that operates through various business segments. The company primarily focuses on diagnostics, developing and commercializing novel diagnostic tests for various conditions. Additionally, Opko Health engages in the production and sale of pharmaceuticals and vaccines, as well as the research and development of new medical technologies. More about Opko Health Inc 's Market Share

Novavax inc Share Performance +1.27% This Quarter

Novavax inc Profile Novavax Inc is a biotechnology company focused on the discovery, development, and commercialization of novel vaccines. They aim to leverage their proprietary recombinant nanoparticle vaccine technology platform to address a wide range of infectious diseases. By collaborating with partners and conducting clinical trials, Novavax works towards bringing innovative vaccines to the global market. More about Novavax inc 's Market Share

Matinas Biopharma Holdings Inc Share Performance -34.18% 30 Days

Matinas Biopharma Holdings Inc Profile Matinas Biopharma Holdings Inc operates as a clinical-stage biopharmaceutical company. Their business model centers around developing therapeutics through the utilization of lipid nano-crystal (LNC) platform technologies. These technologies enable the effective delivery of drugs to improve patient outcomes in various diseases and conditions such as fungal infections, viral infections, and cancer. More about Matinas Biopharma Holdings Inc 's Market Share

Mineralys Therapeutics Inc Share Performance -14.64% One Year

Mineralys Therapeutics Inc Profile Mineralys Therapeutics Inc is a biotechnology company that follows the business model of developing and commercializing novel therapeutics for various diseases. They focus on discovering and advancing small molecule drugs based on innovative research approaches. Their business model is centered around conducting preclinical and clinical trials, obtaining regulatory approvals, and ultimately bringing their therapeutic products to market for improved patient outcomes. More about Mineralys Therapeutics Inc 's Market Share

Sources: Regen Biopharma Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Thursday, September 3, 2026 11:54 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Regen Biopharma Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.